|
0
|
|
Chemogenomic maps reveal a PRDX1-dependent iron-damage axis in the DNA damage response.
(nature.com)
|
O'Loughlin TA
…
Gilbert LA
Nature Chemical Biology
2026-09-08
|
#crispr
#dna damage
#chemogenomics
#cancer
#redox
|
|
0
|
|
CD73 disruption with tumor-specific CRISPR/Cas9 nanoparticles reduces adenosine-mediated immunosuppression and amplifies response to chemotherapy.
(nature.com)
|
Sun X
…
Tay A
Nature Communications
2026-09-08
|
#cancer
#immunotherapy
#crispr
#nanoparticles
#immunosuppression
|
|
0
|
|
FANCM is required for the PAX3::FOXO1-driven oncogenic program in rhabdomyosarcoma.
(linkinghub.elsevier.com)
|
Delaney CD
…
Wood KC
Cell Reports
2026-09-08
|
#crispr
#rhabdomyosarcoma
#oncogene
#replication stress
#dna damage
|
|
0
|
|
In vivo genome-wide CRISPR screens identify FOXR1 as a suppressor of CD8(+) T cell antitumor immunity.
(pnas.org)
|
Yang X
…
Cao X
PNAS
2026-09-08
|
#immunotherapy
#crispr
#t cell
#transcriptomics
#cancer
|
|
0
|
|
Enhanced CRISPR-Cas3-mediated genome editing using circularized crRNAs.
(linkinghub.elsevier.com)
|
Mikamo K
…
Mashimo T
iScience
2026-09-08
|
#crispr
#genome editing
#sequencing
#specificity
|